and their infectious activity, the length of in vitro infection, and other associated 10
tolerizing mechanisms in the periphery 6, 7 In an effort to achieve greater T CD8+ remained around 1% in the spleen ( Figure 1A ) and 10% in the peritoneal cavity 28 ( Figure 1B ). In contrast, several differences were observed when mice were 29 immunized with increasing D2.SV/PR8 cells. While the percentage of NP 366 -specific T CD8+ was constant at around 2% in the spleen and 5% in the peritoneal cavity ( Figure   1 1A, B), the percentage of PA 224 -specific T CD8+ increased gradually ( Figure 1A , B). respectively) ( Figure 3A ). When D2.SV cells were incubated with PR8 killed at 65ºC (D2.SV/PR8-65ºC), there were no detectable residual infectious viral particles within 1 cell lysates ( Figure 3A ). by the plaque assays ( Figure 3A ). Although D2.SV/PR8-56ºC was able to prime 27 NP 366 -and PA 224 -specific T CD8+ , the responses were significantly lower. Initially we were unable to achieve enhanced cross-priming in a reproducible 15 fashion. We discovered that extensive washing of the infected cells was necessary.
16
When D2.SV/PR8 cells were only washed once after infection, the enhancement The overarching aim of this study was to optimize IAV-enhanced cross-priming 
